https://www.selleckchem.com/pr....oducts/Cediranib.htm
This effect ultimately suppressed the induction of c-Fos and NFATc1, which consequently downregulated the expression of the genes required for osteoclast formation and bone resorption. Consistent with our in vitro findings, in vivo administration of Vin protected mice against ovariectomy (OVX)-induced bone loss and trabecular bone deterioration. These results provided promising evidence for the potential therapeutic application of Vin as a novel treatment option against osteolytic diseases. Copyright © 2020 Zhan, Liang, Tian, Che, Wan
Gefällt mir
Kommentar
Teilen
